Inmagene

Inmagene Biopharmaceuticals, a clinical-stage company focused on immunological and inflammatory diseases, has announced topline results from its Phase 2a clinical study of IMG-007 in patients with severe alopecia areata. What Is Inmagene Biopharmaceuticals? Inmagene Biopharmaceuticals was founded to advance therapies targeting immune-mediated and inflammatory conditions. The company develops novel monoclonal antibodies and small molecules, aiming…